Why So Few Drugs for Alzheimer's Disease? Are Methods Failing Drugs?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|7|7|642-651

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.7, Iss.7, 2010-11, pp. : 642-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of ADDL-Targeting Small Molecule Drugs for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 562-567

Bentham Science Publishers

Access to resources Recommend Favorite

Potential use of estrogen-like drugs for the prevention of Alzheimer’s disease

By Smith Jonathan   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 277-281

Humana Press, Inc

Access to resources Recommend Favorite

Sex, drugs and Parkinsons disease

By Ushe Mwiza  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 371-373

Oxford University Press

Access to resources Recommend Favorite

Differential Effects of Two Hexahydropyrroloindole Carbamate-Based Anticholinesterase Drugs on the Amyloid Beta Protein Pathway Involved in Alzheimer Disease

By  

NeuroMolecular Medicine, Vol. 9, Iss. 2, 2007-06 ,pp. : 157-168

Humana Press, Inc

Access to resources Recommend Favorite

Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis

By  

Current Alzheimer Research, Vol. 12, Iss. 8, 2015-01 ,pp. : 761-771

Bentham Science Publishers

Access to resources Recommend Favorite